Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Cumberland Pharmaceuticals Inc. (CPIX) vs Journey Medical Corporation (DERM)

Cumberland Pharmaceuticals Inc. and Journey Medical Corporation are both Drug Manufacturers Specialty & Generic companies. Journey Medical Corporation is the larger, with a market value of $178.4M against $120.0M — 1.5× the size. Cumberland Pharmaceuticals Inc. grew revenue faster over the last twelve months: 32.0% against 20.9%. Journey Medical Corporation has the higher net margin (−8.95% vs −26.2%) and the higher return on invested capital (−5.89% vs −34.2%). Across the 18 metrics below, Journey Medical Corporation leads on 11 and Cumberland Pharmaceuticals Inc. on 7.

Valuation

Metric CPIX DERM Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 2.73 2.48 2.25
P/B 6.66 5.26 1.90
Price to free cash flow 197.97 n/m 16.54
EV/EBITDA n/m 96.75 12.29
EV/Sales 2.89 2.47 2.56
Earnings yield (9.33%) (3.58%) (2.99%)
Free cash flow yield 0.51% (13.32%) 0.00%

Profitability

Metric CPIX DERM Drug Manufacturers Specialty & Generic median
Gross margin 82.80% 65.45% 53.94%
Operating margin (17.39%) (4.41%) 0.00%
Net margin (26.17%) (8.95%) 0.00%
Free cash flow margin 1.38% (10.99%) 0.00%
Return on equity (48.76%) (23.77%) (0.40%)
Return on assets (16.70%) (6.80%) (3.32%)
Return on invested capital (34.23%) (5.89%) 0.00%

Growth

Metric CPIX DERM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 31.98% 20.89% 10.01%
EPS growth (last fiscal year) 58.70% 34.72% —
Revenue growth, 5-year CAGR 3.52% 6.79% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CPIX DERM Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.79 0.05
Current ratio 0.96 1.59 2.31
Net debt to EBITDA (4.58) (0.35) 0.85

Dividend

Metric CPIX DERM Drug Manufacturers Specialty & Generic median
Dividend yield 2.07% — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CPIX DERM Drug Manufacturers Specialty & Generic median
Market cap 120.01m 178.38m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack